2/3
09:39 am
wald
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect
Low
Report
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect
1/30
08:24 am
wald
Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
High
Report
Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
1/28
08:16 am
wald
Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Medium
Report
Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
1/27
09:45 am
wald
UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
Medium
Report
UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
1/27
08:43 am
wald
Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™ [Yahoo! Finance]
Low
Report
Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™ [Yahoo! Finance]
1/27
08:22 am
wald
Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
Low
Report
Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
1/26
12:46 pm
wald
CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Neutral
Report
CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
1/26
08:42 am
wald
Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ [Yahoo! Finance]
Medium
Report
Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ [Yahoo! Finance]
1/26
08:26 am
wald
Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Low
Report
Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
1/23
05:09 am
wald
Waldencast (NASDAQ:WALD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Waldencast (NASDAQ:WALD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
1/21
10:32 am
wald
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler [Yahoo! Finance]
Medium
Report
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler [Yahoo! Finance]
1/21
08:19 am
wald
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler
Medium
Report
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler
1/15
07:47 am
wald
Waldencast (NASDAQ:WALD) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Low
Report
Waldencast (NASDAQ:WALD) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
1/14
08:42 am
wald
Waldencast (NASDAQ:WALD) was given a new $2.00 price target on by analysts at Jefferies Financial Group Inc..
Low
Report
Waldencast (NASDAQ:WALD) was given a new $2.00 price target on by analysts at Jefferies Financial Group Inc..
1/8
10:00 am
wald
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
1/6
12:04 pm
wald
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
Neutral
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
1/1
10:00 am
wald
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
12/30
03:52 pm
wald
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
Neutral
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
12/22
01:51 pm
wald
IBN Named Official Media Partner of Octane's Aesthetics Tech Forum 2026 [Yahoo! Finance]
Low
Report
IBN Named Official Media Partner of Octane's Aesthetics Tech Forum 2026 [Yahoo! Finance]
12/19
10:09 am
wald
Octane to Host Aesthetics Tech Forum 2026 on January 8–9 in Newport Beach, California [Yahoo! Finance]
Low
Report
Octane to Host Aesthetics Tech Forum 2026 on January 8–9 in Newport Beach, California [Yahoo! Finance]
12/11
10:00 am
wald
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
11/29
08:24 am
wald
How Recent Developments Are Shaping the Waldencast Investment Story [Yahoo! Finance]
Medium
Report
How Recent Developments Are Shaping the Waldencast Investment Story [Yahoo! Finance]
11/25
12:51 pm
wald
Waldencast (NASDAQ:WALD) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $5.00 to $4.00. They now have a "buy" rating on the stock.
Low
Report
Waldencast (NASDAQ:WALD) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $5.00 to $4.00. They now have a "buy" rating on the stock.
11/25
07:19 am
wald
Waldencast (NASDAQ:WALD) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
Waldencast (NASDAQ:WALD) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
11/25
06:11 am
wald
Waldencast (NASDAQ:WALD) was downgraded by analysts at Telsey Advisory Group from an "outperform" rating to a "market perform" rating.
Medium
Report
Waldencast (NASDAQ:WALD) was downgraded by analysts at Telsey Advisory Group from an "outperform" rating to a "market perform" rating.